Search Results: Professional 156-587 Examinations Actual Questions - Easy and Guaranteed 156-587 Exam Success ☘ Easily obtain ⮆ 156-587 ⮄ for free download through ⇛ www.pdfvce.com ⇚ 💺156-587 Latest Exam Question
Beginner’s Guide to IND Safety Reporting Under 21 CFR 312(c)
Learn how to ensure compliance with FDA 21 CFR 312.32, and explore Advarra solutions that support efficient and compliant safety reporting.
FDA Guidance on Conducting Clinical Trials During COVID-19 Pandemic
Note: This news item was updated March 31, 2020, to note the new appendix FDA has added to the guidance....
IRB Reference Materials Now Available in Advarra CIRBI Platform
Reference materials and guidance documents for working with Advarra’s IRB are now available in the Advarra Center for IRB Intelligence (CIRBI) Platform.
What Sponsors Need to Know About Medicare Coverage Analysis
Discover the role of MCA in clinical research, its impact on study activation timelines, and how outsourcing can streamline trials.
Advarra Connects Research Stakeholders with Site-Sponsor Consortium
Consortium aims to make clinical trials smarter and more efficient by integrating clinical research site and sponsor technology. (COLUMBIA, MD.)...
Improved Research Workflows Begin with Perspective
Explore cross-industry feedback from stakeholders to better investigate key research workflows.
Advarra Announces SiteIQ™ to Optimize Clinical Trial Feasibility
SiteIQ™ is a new platform that leverages Advarra’s resources and deep domain expertise to provide unique insights on clinical research...
Almac’s Spotlight on IRT Podcast Highlights Advarra Experts
In the latest episode of The Almac Group’s Spotlight on IRT podcast, Advarra Consulting experts Kathy Kelly and Ellen Liedel-Sargent...
ACRP Features Julie Blasingim in Clinical Researcher
Julie Blasingim, MBA, CIP, Director of IRB Reviews at Advarra, was featured in ARCP’s flagship journal, Clinical Researcher, which features...
Clinical Research Leaders Showcase Innovation At Advarra’s Onsemble Conference
Parexel, Moffitt Cancer Center, Duke School of Medicine among speakers at premier clinical research community conference. (COLUMBIA, MD) – Advarra,...
Transfer of IRB Oversight During COVID-19
Time is everything in research, especially right now. If current public health restrictions limit your IRB’s ability to appropriately oversee ongoing research, transfer IRB oversight to Advarra until the original IRB is prepared to re-take oversight. This free service is available through the end of 2020. Fill out this form
Ethical Challenges in Clinical Research During the COVID-19 Pandemic
Luke Gelinas, Advarra IRB Chairperson, co-authored the article “Ethical Challenges in Clinical Research During the COVID-19 Pandemic” in Journal of Bioethical Inquiry.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.